Skip to main content
رجوع
Watch Compare

CytoDyn Inc.

جودة البيانات: 83%
CYDY
OTC Manufacturing Chemicals
KWD 0.29
▲ KWD 0.02 (7.04%)
القيمة السوقية: 392.21 M
السعر
KWD 0.29
القيمة السوقية
392.21 M
نطاق اليوم
KWD 0.28 — KWD 0.29
نطاق 52 أسبوعًا
KWD 0.20 — KWD 0.45
حجم التداول
386,514
فتح KWD 0.29
متوسط 50 يوم / 200 يوم
KWD 0.25
13.78% above
متوسط 50 يوم / 200 يوم
KWD 0.28
3.96% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -17.98 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.37
Interest CoverageN/A

التقييم

PE (TTM)
-10.11
أقل من متوسط القطاع (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -10.1 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -38.79 M
ROE N/A ROA -282.83%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -17.98 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.37
Interest Coverage N/A Asset Turnover N/A
Working Capital -31.99 M Tangible Book Value -104.29 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10.11 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -4.58%
Market Cap 392.21 M Enterprise Value 417.09 M
Per Share
EPS (Diluted TTM) -0.04 Revenue / Share N/A
FCF / Share -0.01 OCF / Share -0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 46.35%
SBC-Adj. FCF -19.13 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — 0.0 266,000.0 —
Net Income 3.75 M -49.84 M -79.82 M -210.82 M -154.67 M
EPS (Diluted) 0.00 -0.05 -0.10 -0.31 —
Gross Profit — — 213,000.0 213,000.0 —
Operating Income 9.66 M -18.06 M -40.58 M -145.40 M -104.60 M
EBITDA — — — — —
R&D Expenses — 7.24 M 2.63 M 27.04 M 58.43 M
SG&A Expenses — — — — —
D&A 18,000.0 29,000.0 175,000.0 781,000.0 —
Interest Expense — 31.78 M 39.25 M 65.42 M —
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 18.05 M 11.14 M 11.29 M 29.19 M 132.08 M
Total Liabilities 114.09 M 127.89 M 120.79 M 123.58 M 153.10 M
Shareholders' Equity -96.04 M -116.76 M -109.50 M -94.40 M -21.02 M
Total Debt 45.35 M 45.02 M 45.73 M 42.22 M —
Cash & Equivalents 11.90 M 3.11 M 2.54 M 4.23 M 33.94 M
Current Assets 17.88 M 10.82 M 10.81 M 10.52 M 129.58 M
Current Liabilities 70.52 M 84.18 M 119.80 M 123.16 M 152.55 M